113 related articles for article (PubMed ID: 33895680)
1. ETV6-NTRK3 translocation-associated low-grade mucinous bronchial adenocarcinoma: A novel bronchial salivary gland-type non-small cell lung cancer subtype.
von der Thüsen JH; Dumoulin DW; Maat APWM; Wolf J; Sadeghi AH; Aerts JGJV; Cornelissen R
Lung Cancer; 2021 Jun; 156():72-75. PubMed ID: 33895680
[TBL] [Abstract][Full Text] [Related]
2. Expanding the Molecular Spectrum of Secretory Carcinoma of Salivary Glands With a Novel VIM-RET Fusion.
Skálová A; Banečkova M; Thompson LDR; Ptáková N; Stevens TM; Brcic L; Hyrcza M; Michal M; Simpson RHW; Santana T; Michal M; Vaněček T; Leivo I
Am J Surg Pathol; 2020 Oct; 44(10):1295-1307. PubMed ID: 32675658
[TBL] [Abstract][Full Text] [Related]
3. Characterization of an ETV6-NTRK3 rearrangement with unusual, but highly significant FISH signal pattern in a secretory carcinoma of the salivary gland: a case report.
Wagner F; Greim R; Krebs K; Luebben F; Dimmler A
Diagn Pathol; 2021 Aug; 16(1):73. PubMed ID: 34372873
[TBL] [Abstract][Full Text] [Related]
4. Novel gene fusions in secretory carcinoma of the salivary glands: enlarging the ETV6 family.
Guilmette J; Dias-Santagata D; Nosé V; Lennerz JK; Sadow PM
Hum Pathol; 2019 Jan; 83():50-58. PubMed ID: 30130630
[TBL] [Abstract][Full Text] [Related]
5. Mammary Analogue Secretory Carcinoma of Salivary Glands: Molecular Analysis of 25 ETV6 Gene Rearranged Tumors With Lack of Detection of Classical ETV6-NTRK3 Fusion Transcript by Standard RT-PCR: Report of 4 Cases Harboring ETV6-X Gene Fusion.
Skálová A; Vanecek T; Simpson RH; Laco J; Majewska H; Baneckova M; Steiner P; Michal M
Am J Surg Pathol; 2016 Jan; 40(1):3-13. PubMed ID: 26492182
[TBL] [Abstract][Full Text] [Related]
6. Low-grade tracheal adenocarcinoma with ETV6::NTRK3 fusion: unique morphology akin to subsets of sinonasal low-grade non-intestinal-type adenocarcinoma.
Kishikawa S; Hayashi T; Shimizu J; Fuwa B; Nonomura A; Saito T; Yatabe Y; Yao T
Virchows Arch; 2022 Nov; 481(5):793-797. PubMed ID: 35670854
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological characteristics and outcome of 31 patients with ETV6-NTRK3 fusion gene confirmed (mammary analogue) secretory carcinoma of salivary glands.
Boon E; Valstar MH; van der Graaf WTA; Bloemena E; Willems SM; Meeuwis CA; Slootweg PJ; Smit LA; Merkx MAW; Takes RP; Kaanders JHAM; Groenen PJTA; Flucke UE; van Herpen CML
Oral Oncol; 2018 Jul; 82():29-33. PubMed ID: 29909898
[TBL] [Abstract][Full Text] [Related]
8. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity.
Skálová A; Vanecek T; Sima R; Laco J; Weinreb I; Perez-Ordonez B; Starek I; Geierova M; Simpson RH; Passador-Santos F; Ryska A; Leivo I; Kinkor Z; Michal M
Am J Surg Pathol; 2010 May; 34(5):599-608. PubMed ID: 20410810
[TBL] [Abstract][Full Text] [Related]
9. Pan-Trk immunohistochemistry is a sensitive and specific ancillary tool for diagnosing secretory carcinoma of the salivary gland and detecting ETV6-NTRK3 fusion.
Xu B; Haroon Al Rasheed MR; Antonescu CR; Alex D; Frosina D; Ghossein R; Jungbluth AA; Katabi N
Histopathology; 2020 Feb; 76(3):375-382. PubMed ID: 31448442
[TBL] [Abstract][Full Text] [Related]
10. High-grade non-intestinal type sinonasal adenocarcinoma with ETV6::NTRK3 fusion, distinct from secretory carcinoma by immunoprofile and morphology.
Klubíčková N; Mosaieby E; Ptáková N; Trinquet A; Laé M; Costes-Martineau V; Skálová A
Virchows Arch; 2023 Aug; 483(2):187-195. PubMed ID: 37415052
[TBL] [Abstract][Full Text] [Related]
11. Mammary analogue secretory carcinoma of salivary glands: a clinicopathologic and molecular study including 2 cases harboring ETV6-X fusion.
Ito Y; Ishibashi K; Masaki A; Fujii K; Fujiyoshi Y; Hattori H; Kawakita D; Matsumoto M; Miyabe S; Shimozato K; Nagao T; Inagaki H
Am J Surg Pathol; 2015 May; 39(5):602-10. PubMed ID: 25651470
[TBL] [Abstract][Full Text] [Related]
12. ETV6::NTRK3 gene fusion in a patient with metastatic lung atypical carcinoid successfully treated with repotrectinib: A case report.
Gao L; Ai X; Lu S
Lung Cancer; 2024 Jan; 187():107443. PubMed ID: 38113652
[TBL] [Abstract][Full Text] [Related]
13. Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimics by the presence of the ETV6-NTRK3 translocation and novel surrogate markers.
Urano M; Nagao T; Miyabe S; Ishibashi K; Higuchi K; Kuroda M
Hum Pathol; 2015 Jan; 46(1):94-103. PubMed ID: 25456394
[TBL] [Abstract][Full Text] [Related]
14. Mammary analog secretory carcinoma of salivary gland with high-grade histology arising in hard palate, report of a case and review of literature.
Luo W; Lindley SW; Lindley PH; Krempl GA; Seethala RR; Fung KM
Int J Clin Exp Pathol; 2014; 7(12):9008-22. PubMed ID: 25674280
[TBL] [Abstract][Full Text] [Related]
15. Salivary Secretory Carcinoma Harboring a Novel ALK Fusion: Expanding the Molecular Characterization of Carcinomas Beyond the ETV6 Gene.
Sasaki E; Masago K; Fujita S; Suzuki H; Hanai N; Hosoda W
Am J Surg Pathol; 2020 Jul; 44(7):962-969. PubMed ID: 32205481
[TBL] [Abstract][Full Text] [Related]
16. Mammary analogue secretory carcinoma of salivary glands: a new entity associated with ETV6 gene rearrangement.
Majewska H; Skálová A; Stodulski D; Klimková A; Steiner P; Stankiewicz C; Biernat W
Virchows Arch; 2015 Mar; 466(3):245-54. PubMed ID: 25503077
[TBL] [Abstract][Full Text] [Related]
17. Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, β-catenin, EGFR, and CCND1 genes.
Skálová A; Vanecek T; Majewska H; Laco J; Grossmann P; Simpson RH; Hauer L; Andrle P; Hosticka L; Branžovský J; Michal M
Am J Surg Pathol; 2014 Jan; 38(1):23-33. PubMed ID: 24145651
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic and molecular characterization of mammary analogue secretory carcinoma of salivary gland origin.
Baghai F; Yazdani F; Etebarian A; Garajei A; Skalova A
Pathol Res Pract; 2017 Sep; 213(9):1112-1118. PubMed ID: 28781197
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemistry with a pan-TRK antibody distinguishes secretory carcinoma of the salivary gland from acinic cell carcinoma.
Hung YP; Jo VY; Hornick JL
Histopathology; 2019 Jul; 75(1):54-62. PubMed ID: 30801752
[TBL] [Abstract][Full Text] [Related]
20. ETV6::NTRK3-associated papillary adenocarcinoma: let us play it by ear.
Bell D; Maghami E; Bakkar R; Afkhami M
Virchows Arch; 2024 Jan; ():. PubMed ID: 38206384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
